Psyence Biomedical (PBM) Enterprise Value (2023 - 2025)

Psyence Biomedical's Enterprise Value history runs 3 years deep, the most recent figure standing at -$7.2 million for Q3 2025.

• In Q3 2025, Enterprise Value fell 266.8% year-over-year to -$7.2 million; the TTM figure through Sep 2025 stood at -$7.2 million (down 266.8% YoY), while the FY2025 annual figure was -$6.2 million, down 709.01% from the prior year.
• Enterprise Value was -$7.2 million for Q3 2025 at Psyence Biomedical, down from -$6.2 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$762799.0 in Q1 2024 to a low of -$7.2 million in Q3 2025.
• Historically, Enterprise Value has averaged -$3.5 million across 3 years, with a median of -$2.0 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value soared 44.07% in 2024, then sank 709.01% in 2025.
• A 3-year view of Enterprise Value shows it stood at -$1.4 million in 2023, then slumped by 43.87% to -$2.0 million in 2024, then slumped by 266.8% to -$7.2 million in 2025.
• The last three Enterprise Value figures came in at -$7.2 million (Q3 2025), -$6.2 million (Q1 2025), and -$2.0 million (Q3 2024), per Business Quant data.